Insight Molecular Diagnostics vs Pulse Biosciences
Insight Molecular Diagnostics is the larger business, with $4.1m of revenue in fiscal 2025 against $350,000 for Pulse Biosciences (11.6 times as much). Insight Molecular Diagnostics kept more of each dollar of sales as profit: a net margin of -1238.5% against -20794.6%.
| Latest fiscal year | Insight Molecular DiagnosticsIMDX, 2025 | Pulse BiosciencesPLSE, 2025 |
|---|---|---|
| Revenue | $4.1m | $350,000 |
| Revenue growth | 115.6% | — |
| Net income | −$50.2m | −$72.8m |
| Operating margin | — | — |
| Net margin | -1238.5% | -20794.6% |
| Return on equity | — | -74.4% |
| Free cash flow | −$25.4m | −$54.4m |
| Cash | $11.6m | $80.7m |
| Total debt | $0 | $0 |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 116 |
| Market value | $91.3m | $3.66bn |
| Price vs our value range | — | — |
| Moat score | 20 (Weak) | — |
| Insider trades, 12 months | 14 buys, 0 sales | 8 buys, 7 sales |